SCHEMBL4894576

SCHEMBL4894576

CCc1ccc(S(=O)(=O)NCCc2ccc3sc(-c4ccccc4)nc3c2)cc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.49
NFKB1 P19838 3/20 0.49
RAB9A P51151 3/20 0.49
NFKB2 Q00653 3/20 0.49
RELA Q04206 3/20 0.49
PKM P14618 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HPGD P15428 2/20 0.49
KDM4E B2RXH2 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
STAT1 P42224 1/20 0.47
ILK Q13418 2/20 0.45
TP53 P04637 2/20 0.44
LMNA P02545 1/20 0.43
THRB P10828 1/20 0.43
AKR1C3 P42330 4/20 0.43
MAPT P10636 1/20 0.43
HDAC6 Q9UBN7 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905795 0.92 NPC1 (0.52) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL4902822 0.90 LMNA (0.52) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL4902516 0.88 NPC1 (0.48) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL4906970 0.85 NFKB1 (0.49) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL4895876 0.85 NPC1 (0.53) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL4904176 0.83 NPC1 (0.52) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL4904651 0.82 PTPN5 (0.55) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL4904070 0.80 NPC1 (0.52) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL5373585 0.79 ALDH1A1 (0.56) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL4894588 0.77 LMNA (0.48) NPC1NFKB1RAB9ANFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101287718-A Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER PROD INC (US) 2008-10-15 CN claimed
EP-1765796-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS Pfizer Products Inc. (US) 2007-03-28 EP claimed
WO-2006003495-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER PRODUCTS INC. (US) 2006-01-12 WO claimed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US claimed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD NPC1 50/4885NFKB1 1696/4885RAB9A 2581/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD NPC1 59/4885NFKB1 1853/4885RAB9A 2271/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD NPC1 59/4885NFKB1 1853/4885RAB9A 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.